Bendroflumethiazide

New Zealand - English - Medsafe (Medicines Safety Authority)

Buy It Now

Active ingredient:
Bendroflumethiazide 2.5 mg;  ;  
Available from:
Ipca Pharma (NZ) Pty Limited
INN (International Name):
Bendroflumethiazide 2.5 mg
Dosage:
2.5 mg
Pharmaceutical form:
Tablet
Composition:
Active: Bendroflumethiazide 2.5 mg     Excipient: Lactose Purified talc Starch Stearic acid
Units in package:
Blister pack, PVC/PVDC, 14 tablets
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
Ipca Laboratories Limited
Therapeutic indications:
Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Product summary:
Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-7756a
Authorization date:
2006-06-28

Similar products

Search alerts related to this product

Share this information